Bosh sahifaAM6 • FRA
Amicus Therapeutics, Inc.
9,10 €
30-yan, 23:46:46 (GMT+1) · EUR · FRA · Ogohlantirish
AksiyalarDE qimmatli qogʻozi
Yopilish kursi
9,10 €
Kunlik diapazon
9,10 € - 9,10 €
Yillik diapazon
8,20 € - 12,90 €
Bozor kapitalizatsiyasi
2,88 mlrd USD
Oʻrtacha hajm
45,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD)sen, 2024Y/Y qiyosi
Daromad
141,52 mln36,73%
Joriy xarajat
103,44 mln-4,74%
Sof foyda
-6,73 mln68,81%
Sof foyda marjasi
-4,7577,22%
Har bir ulushga tushum
0,10242,86%
EBITDA
26,97 mln310,72%
Amaldagi soliq stavkasi
199,17%
Jami aktivlari
Jami passivlari
(USD)sen, 2024Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
249,76 mln-10,90%
Jami aktivlari
786,56 mln2,94%
Jami passivlari
607,73 mln-3,66%
Umumiy kapital
178,82 mln
Tarqatilgan aksiyalar
298,81 mln
Narxi/balansdagi bahosi
15,17
Aktivlardan daromad
8,07%
Kapitaldan daromad
10,33%
Naqd pulning sof oʻzgarishi
(USD)sen, 2024Y/Y qiyosi
Sof foyda
-6,73 mln68,81%
Operatsiyalardan naqd pul
-22,97 mln40,10%
Sarmoyadan naqd pul
34,27 mln-4,17%
Moliyadan naqd pul
18,19 mln-51,65%
Naqd pulning sof oʻzgarishi
24,46 mln-52,90%
Boʻsh pul
-28,79 mln-466,77%
Haqida
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Tashkil etilgan
4-fev, 2002
Xodimlar soni
517
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu